Search results
Results from the WOW.Com Content Network
The 2015 update of guidelines of the Association of Gynecological Oncology (AGO), an autonomous community of the German Society of Gynecology and Obstetrics (DGGG) and the German Cancer Society includes TARGIT IORT during lumpectomy as a recommended option for women with a T1, Grade 1 or 2, ER positive breast cancer. [5]
Superficial X-rays are low-energy X-rays that do not penetrate very far before they are absorbed. They are produced by X-ray tubes operating at voltages in the 10–100 kV range, and therefore have peak energies in the 10–100 keV range. [1] The Maximar-100 was a widely-adopted superficial radiation therapy unit.
Radiation therapy (RT) is in itself painless, but has iatrogenic side effect risks. Many low-dose palliative treatments (for example, radiation therapy to bony metastases) cause minimal or no side effects, although short-term pain flare-up can be experienced in the days following treatment due to oedema compressing nerves in the treated area ...
The Maximar-100 is a radiation therapy device that was made by General Electric to deliver superficial x-rays. Maximar 100 X-Ray Unit Superficial Therapy. The Maximar-100's x-ray source is the GE SRT-1, [1] an x-ray tube specifically designed for use in the Maximar-100. This is a fixed-anode, reflection-type x-ray tube, whose name is composed ...
Doctor reviewing a radiation treatment plan. In radiotherapy, radiation treatment planning (RTP) is the process in which a team consisting of radiation oncologists, radiation therapist, medical physicists and medical dosimetrists plan the appropriate external beam radiotherapy or internal brachytherapy treatment technique for a patient with cancer.
Body sites in which brachytherapy can be used to treat cancer. Brachytherapy is commonly used to treat cancers of the cervix, prostate, breast, and skin. [1]Brachytherapy can also be used in the treatment of tumours of the brain, eye, head and neck region (lip, floor of mouth, tongue, nasopharynx and oropharynx), [10] respiratory tract (trachea and bronchi), digestive tract (oesophagus, gall ...
The U.S. Preventative Services Task Force (USPSTF) has finalized new breast cancer screening guidelines for women ages 40 to 74.
A specific thickness of bolus can be applied to the skin to alter the dose received at depth in the tissue and on the skin surface. A typical example of this is the application of a defined thickness of bolus to a chest wall for post-mastectomy chest wall treatment, to increase the skin dose.